标题
Antiangiogenic therapy: impact on invasion, disease progression and metastasis
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 8, Issue 4, Pages 210-221
出版商
Springer Nature
发表日期
2011-03-03
DOI
10.1038/nrclinonc.2011.21
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape
- (2011) E. di Tomaso et al. CANCER RESEARCH
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
- (2010) M. Reck et al. ANNALS OF ONCOLOGY
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
- (2010) Carlos H. Barrios et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation-mediated promotion of invasion and metastasis
- (2010) Graziella Solinas et al. CANCER AND METASTASIS REVIEWS
- Progression-Free Survival Is Simply a Measure of a Drug’s Effect While Administered and Is Not a Surrogate for Overall Survival
- (2010) Julia Wilkerson et al. CANCER JOURNAL
- Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
- (2010) Y.-J. Lee et al. CANCER RESEARCH
- Cediranib/AZD2171 Inhibits Bone and Brain Metastasis in a Preclinical Model of Advanced Prostate Cancer
- (2010) J. J. Yin et al. CANCER RESEARCH
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- (2010) W. B. Nagengast et al. CANCER RESEARCH
- The autophagic tumor stroma model of cancer or “battery-operated tumor growth”
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy
- (2010) A. Bagri et al. CLINICAL CANCER RESEARCH
- Modeling metastasis in the mouse
- (2010) Paula D Bos et al. CURRENT OPINION IN PHARMACOLOGY
- Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
- (2010) Amir Abdollahi et al. DRUG RESISTANCE UPDATES
- Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination
- (2010) Einar K. Rofstad et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative induction with sorafenib pathologically downstaged advanced renal cell carcinoma: A case report
- (2010) Tatsuya Kinoshita et al. INTERNATIONAL JOURNAL OF UROLOGY
- The Efficacy and Safety of Sunitinib in Korean Patients with Advanced Renal Cell Carcinoma: High Incidence of Toxicity Leads to Frequent Dose Reduction
- (2010) C. Yoo et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer
- (2010) Nasser Altorki et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study
- (2010) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
- (2010) Paul J. Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?
- (2010) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
- (2010) David Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Health-Related Quality of Life 5 Years After SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial
- (2010) Juanita Mary Crook et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
- (2010) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiographic patterns of relapse in glioblastoma
- (2010) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma
- (2010) Richard M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of irradiation on tumor cell survival, invasion and angiogenesis
- (2010) Odysseas Kargiotis et al. JOURNAL OF NEURO-ONCOLOGY
- Molecular Imaging of Changes in the Prevalence of Vascular Endothelial Growth Factor Receptor in Sunitinib-Treated Murine Mammary Tumors
- (2010) Z. Levashova et al. JOURNAL OF NUCLEAR MEDICINE
- Is there really a yin and yang to VEGF-targeted therapies?
- (2010) Lee M Ellis et al. LANCET ONCOLOGY
- Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
- (2010) Debashish Bose et al. LANCET ONCOLOGY
- Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial
- (2010) Roy S Herbst et al. LANCET ONCOLOGY
- Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes
- (2010) Jung Eun Park et al. MOLECULAR & CELLULAR PROTEOMICS
- Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
- (2010) H. J. Hammers et al. MOLECULAR CANCER THERAPEUTICS
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Raising the bar for cancer therapy models
- (2010) Giulio Francia et al. NATURE BIOTECHNOLOGY
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- (2010) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Lost in migration
- (2010) George S Mack et al. NATURE BIOTECHNOLOGY
- Progression of intramedullary metastasis during perioperative cessation of sunitinib
- (2010) Fausto Petrelli et al. Nature Reviews Urology
- Bevacizumab in recurrent high-grade pediatric gliomas
- (2010) A. Narayana et al. NEURO-ONCOLOGY
- Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
- (2010) Anil Bagri et al. TRENDS IN MOLECULAR MEDICINE
- The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases
- (2009) Ingrid M. E. Desar et al. ACTA ONCOLOGICA
- Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors
- (2009) Pascal Wolter et al. ACTA ONCOLOGICA
- Cultural competence in oncology: where do we stand?
- (2009) A. Surbone ANNALS OF ONCOLOGY
- Thrombosis associated with angiogenesis inhibitors
- (2009) Francesca Elice et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- (2009) Joost JC Verhoeff et al. BMC CANCER
- Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon
- (2009) Elizabeth R. Plimack et al. CANCER
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Sunitinib Prolongs Survival in Genetically Engineered Mouse Models of Multistep Lung Carcinogenesis
- (2009) L. Gandhi et al. Cancer Prevention Research
- Targeting Angiogenesis from Premalignancy to Metastases
- (2009) J. R. Grandis et al. Cancer Prevention Research
- It takes two to tango: Combinations of conventional cytotoxics with compounds targeting the vascular endothelial growth factorâvascular endothelial growth factor receptor pathway in patients with solid malignancies
- (2009) Ingrid A. Boere et al. CANCER SCIENCE
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Preclinical Drug Development Must Consider the Impact on Metastasis
- (2009) P. S. Steeg et al. CLINICAL CANCER RESEARCH
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
- (2009) Annamaria Rapisarda et al. DRUG RESISTANCE UPDATES
- Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma
- (2009) Joost J.C. Verhoeff et al. EUROPEAN JOURNAL OF CANCER
- Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
- (2009) Ahlame Saidi et al. INTERNATIONAL JOURNAL OF CANCER
- Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis
- (2009) Maria Galluzzo et al. JOURNAL OF CLINICAL INVESTIGATION
- Bisphosphonates and Bone Turnover in Premenopausal Women Receiving Adjuvant Chemotherapy
- (2009) Alexander Paterson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2009) M.P. Sablin et al. JOURNAL OF UROLOGY
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis
- (2009) T. Schomber et al. MOLECULAR CANCER THERAPEUTICS
- The nuances of therapy
- (2009) Lee M. Ellis et al. NATURE
- Avastin-Tarceva combination fails in lung cancer
- (2009) Dan Jones NATURE BIOTECHNOLOGY
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Anticancer strategies involving the vasculature
- (2009) Victoria L. Heath et al. Nature Reviews Clinical Oncology
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
- (2009) F. M. Iwamoto et al. NEUROLOGY
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- VEGFR1 Activity Modulates Myeloid Cell Infiltration in Growing Lung Metastases but Is Not Required for Spontaneous Metastasis Formation
- (2009) Michelle R. Dawson et al. PLoS One
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies
- (2009) Yongping Crawford et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sorafenib for Metastatic Renal Cancer
- (2008) Rachel P. Riechelmann et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery
- (2008) W. Cacheux et al. ANNALS OF ONCOLOGY
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- (2008) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
- (2008) D. D. Hu-Lowe et al. CLINICAL CANCER RESEARCH
- Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
- (2008) Manfred Johannsen et al. EUROPEAN UROLOGY
- Bevacizumab Beyond Progression: Does This Make Sense?
- (2008) Lee M. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
- (2008) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
- (2008) R. M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
- (2008) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
- (2008) T. P. Padera et al. MOLECULAR CANCER THERAPEUTICS
- High-grade glioma before and after treatment with radiation and Avastin: Initial observations
- (2008) Ingeborg Fischer et al. NEURO-ONCOLOGY
- VEGF Trap induces antiglioma effect at different stages of disease
- (2008) Candelaria Gomez-Manzano et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab Reduces the Growth Rate Constants of Renal Carcinomas: A Novel Algorithm Suggests Early Discontinuation of Bevacizumab Resulted in a Lack of Survival Advantage
- (2008) W. D. Stein et al. ONCOLOGIST
- The effect of bevacizumab (Avastin) on neuroimaging of brain metastases
- (2008) Marlon S. Mathews et al. SURGICAL NEUROLOGY
- Metastasis: a therapeutic target for cancer
- (2008) Patricia S Steeg et al. Nature clinical practice. Oncology
- Antitumor Effects of Sunitinib or Sorafenib in Patients With Metastatic Renal Cell Carcinoma Who Received Prior Antiangiogenic Therapy
- (2007) Ila Tamaskar et al. JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started